Specialised in Formulation and API research, Alkem houses a total of 16 manufacturing facilities, 13 for Finished dosage formulations and 3 for Active Pharmaceutical Ingredients. 14 of them located across India and 2 located in the USA.

Alkem’s state-of-the-art R&D centre has an expertise in developing Formulation nearing patent expiry, Non-infringing formulation, Value added Generics, TDDS and NDDS.
We have an in-house dedicated Regulatory Team for global filings and a proficient Intellectual Property Cell.
Our Bioequivalence Centre in Taloja, Mumbai (India) is a well-equipped clinical research centre certified by USFDA, EMA and TGA. It is Currently a 100-bed facility.